Industry News

United States : NATCO Pharmas partner Mylan applies for Copaxone generic
Local company preps for growth with headquarter building plans
InnoPharma Announces FDA Approval of Decitabine for Injection, a Generic Version of DACOGEN�
Canada's Lawson Health Research Institute Investigates Groundbreaking New Technology to Monitor Cerebral Blood Flow in Cardiac Surgery Patients
Pfizer Investigational Vaccine for Clostridium Difficile Receives Fast Track Designation
NIH to Launch Human Safety Study of Ebola Vaccine Candidate
CDC Boss Bemoans Liberia - 'Worst Ever Ebola Outbreak'
NIH to Launch Human Safety Study of Ebola Vaccine Candidate
Local company preps for growth with headquarter building plans
ISPE Releases First Look at its Plan to Prevent Drug Shortages
CDC Boss Bemoans Liberia - 'Worst Ever Ebola Outbreak'
Amneal Pharmaceuticals Announces Four New Generics Amneal Pharmaceuticals
New type 2 diabetes treatment Jardiance (empagliflozin) tablets for adults now available in U.S. pharmacies New JARDIANCE Simple Savings program currently offered in doctors' offices and online
Fresenius Kabi Receives FDA approval for Kabiven and Perikabiven
Roche to buy US biotech firm InterMune for $8.3billion
Janssen Affiliate Cilag GmbH International Acquires Covagen AG Clinical Candidate COVA 322 and FynomAb Technology Platform Further Strengthen Immunology Portfolio and Capabilities
Iroko Pharmaceuticals Gains FDA Approval of ZORVOLEX for Management of Osteoarthritis Pain New Indication in Chronic Pain Marks Company's Third FDA Approval in Less Than a Year
Nipro Diagnostics Announces FDA Clearance of its Newest Blood Glucose Monitoring Systems, TRUE METRIX and TRUE METRIX PRO, and Expansion of...
DGAP-News: EDMOND DE ROTHSCHILD INVESTMENT PARTNERS SELLS ITS POSITION IN COVAGEN AG TO JANSSEN AFFILIATE CILAG GMBH INTERNATIONAL, A JOHNSON & JOHNSON COMPANY
VIVUS Announces Acquisition of Topiramate-Related Patents From Janssen Pharmaceuticals
Janssen Affiliate Cilag GmbH International Acquires Covagen AG Clinical Candidate COVA 322 and FynomAb Technology Platform Further Strengthen Immunology Portfolio and Capabilities
Iroko Pharmaceuticals Gains FDA Approval of ZORVOLEX for Management of Osteoarthritis Pain New Indication in Chronic Pain Marks Company's Third FDA Approval in Less Than a Year
VIVUS Announces Acquisition of Topiramate-Related Patents From Janssen Pharmaceuticals
Insys Therapeutics Receives FDA Orphan Drug Designation for Its Pharmaceutical Cannabidiol as a Potential Treatment for Glioblastoma Multiforme
Insys Therapeutics Receives FDA Orphan Drug Designation for Its Pharmaceutical Cannabidiol as a Potential Treatment for Glioblastoma Multiforme